Clinical Trial Update: Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating PRN ranibizumab regimen for macular edema caused by branch retinal vein occlusion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Branch Retinal Vein Occlusion
• Macular Edema

Drugs mentioned

• Ranibizumab (ranibizumab)

Snippet

Sponsor: Nagoya City University | Conditions: Branch Retinal Vein Occlusion | Phase 4 | Status: COMPLETED